ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1155

The Status of Latin-American Women in Rheumatology

Genessis Maldonado1, Maria Intriago 1, Enrique Soriano 2 and Carlos Rios 1, 1Universidad Espiritu Santo, Guayaquil, Ecuador, 2Rheumatology Section, Internal Medicine Service, Hospital Italiano de Buenos Aires, Argentina., Buenos Aires, Buenos Aires, Argentina

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: socioeconomic factors and socioeconomic status

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 11, 2019

Title: Healthcare Disparities In Rheumatology Poster

Session Type: Poster Session (Monday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Currently, Latin America does not have detailed information of women in rheumatologists based on education, working conditions, productivity, distribution of time between work activities and job satisfaction. The purpose of this survey was to provide more information of the rheumatology women in Latin America.

Methods: A digital survey was created using the Google Forms platform, it was approved and endorsed by the scientific committee of PANLAR and later sent to the different rheumatology associations of the region. The data was analyzed in the statistical program SPSS v.23.

Results: There were 318 women with an average age of 44 ± 10.7 [25-71], mostly mestizo ethnicity 60%, white 38%, indigenous 1%, African American 1% and Asian 1%. 58% are married, 28% are single, 8% are divorced, 5% are in free-union and 2% are widows. The mean number of children was 1.21 ± 1.11 [0-5]. The country with the largest number of rheumatologists was Argentina 32%, Brazil 16% and Mexico 11%. 37% of rheumatologists had at least one comorbidity, 17% thyroid disease, 7% osteoarthritis, 6% hypertension, 4% diabetes, 4% depression, 4% autoimmune diseases, 1% artery disease and 1% gout. 35% work in private hospitals, 27% private practice, 21% in government hospitals, 16% university hospitals and 1% in non-profit organizations. 86% is dedicated to adult rheumatology, 20% internal medicine, 15% pediatric rheumatology and 2% to immunology. The average of weekly work hours was 39.4 ± 18.3 [4-120], male rheumatologist weekly hours mean was 38.3 ± 17.1 [0-120]. 29% have training in musculoskeletal ultrasound, 75% training in densitometry reading and 50% training in musculoskeletal MRI. 72% have access to early arthritis clinic. 39% have an annual income below 19K, 19% between 20-29K, 11% between 30-39K, 14% between 50-99K, 9% between 40-49K and only 8% earn above 100K per year compared to male rheumatologist which 27% have an annual income below 19K, 12% between 20-29K, 12% between 30-39K, 19% between 50-99K, 10% between 40-49K and 20% earn above 100K per year. Regarding the satisfaction of the general practice, the average was 5.2 ± 1.25 [0-7], career options / professional growth 4.16 ± 2.01[0-7], geographic location 4.57 ± 2.11[0-7], income salary 3.2 ± 1.78 [0-7], job security 3.40 ± 1.87[0-7], colleagues and coworkers 4.42 ± 2.07[0-7]. 59% have a malpractice insurance. 88% have medical insurance and 70% retirement plan.

Conclusion: There are more women rheumatologist in the region compare to male rheumatologist. Women rheumatologist feel satisfied with their clinical practice, however, compared to male rheumatologist women have a lower annual income. This is the first study of its kind in Latin America. 


Disclosure: G. Maldonado, None; M. Intriago, None; E. Soriano, Abbvie, 2, 5, 8, ABBVIE, 2, 5, 8, AbbVie, 2, 5, 8, Amber, 8, Amgen, 5, 8, AMGEN, 5, 8, BMS, 8, BRISTOL, 8, Bristol MS, 8, BRISTOL MYERS SQUIBB, 8, Bristol-Myers Squibb, 8, eli lilly, 5, 8, Genzyme, 8, GENZYME, 8, GLAXO, 2, Glaxo, 2, glaxosmithkline, 2, GlaxoSmithKline, 2, GSK, 2, Janssen, 8, Lilly, 5, 8, LILLY, 5, 8, Novartis, 2, 5, 8, NOVARTIS, 2, 5, 8, PFIZER, 5, 8, Pfizer, 5, 8, Pfizer Inc, 5, 8, Roche, 2, 8, ROCHE, 2, 8, Sandoz, 5, SANDOZ, 5, Sanofi, 5, SANOFI, 5, SANOPHY, 5, UCB, 8; C. Rios, None.

To cite this abstract in AMA style:

Maldonado G, Intriago M, Soriano E, Rios C. The Status of Latin-American Women in Rheumatology [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/the-status-of-latin-american-women-in-rheumatology/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/the-status-of-latin-american-women-in-rheumatology/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology